These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17971079)

  • 1. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology.
    Mondragón-Rodríguez S; Mena R; Binder LI; Smith MA; Perry G; García-Sierra F
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):62-75. PubMed ID: 17971079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
    Mondragón-Rodríguez S; Basurto-Islas G; Santa-Maria I; Mena R; Binder LI; Avila J; Smith MA; Perry G; García-Sierra F
    Int J Exp Pathol; 2008 Apr; 89(2):81-90. PubMed ID: 18336525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
    Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.
    King ME; Ghoshal N; Wall JS; Binder LI; Ksiezak-Reding H
    Am J Pathol; 2001 Apr; 158(4):1481-90. PubMed ID: 11290566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of filaments from Pick's disease reveal a novel tau protein fold.
    Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M
    Nature; 2018 Sep; 561(7721):137-140. PubMed ID: 30158706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
    Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
    J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy.
    Ferrer I; Hernández I; Puig B; Rey MJ; Ezquerra M; Tolosa E; Boada M
    J Alzheimers Dis; 2003 Dec; 5(6):445-54. PubMed ID: 14757934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.
    Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I
    Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-repeat tau-positive Pick body-like inclusions are distinct from classic Pick bodies.
    Motoi Y; Iwamoto H; Itaya M; Kobayashi T; Hasegawa M; Yasuda M; Mizuno Y; Mori H
    Acta Neuropathol; 2005 Oct; 110(4):431-3. PubMed ID: 16158330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.